Associations of plasma testosterone with clinical manifestations in acute panic disorder
- PMID: 30471570
- DOI: 10.1016/j.psyneuen.2018.11.017
Associations of plasma testosterone with clinical manifestations in acute panic disorder
Abstract
The probable implication of testosterone in the neurobiology of anxiety disorders, and particularly panic disorder (PD), is poorly studied. We explored for potential differences concerning testosterone (T) plasma levels and the ratio testosterone/cortisol (T/C) between medication-free, consecutively-referred patients with acute exacerbation of PD comorbid with agoraphobia (PDA) (N = 40; females = 24; age = 31.4 ± 7.1 years) and healthy controls (N = 80; females = 48; matched for age). Moreover, we investigated for potential associations of T levels and T/C ratio with the severity of acute PDA psychopathology in the patients of the sample. Psychometric measures included panic attacks' number during last three weeks (PA-21days), the Agoraphobic Cognitions Questionnaire (ACQ) and the Hamilton Anxiety Rating Scale (HARS). Male patients -but not female ones- demonstrated significantly lower T levels compared to controls. Moreover, in male patients, a significant inverse association emerged between T/C ratio and PA-21days, so that lower T/C ratio is associated with significantly more panic attacks. On the contrary, female patients demonstrated significant positive associations: (a) between T levels and PDA-related pathological cognitions (ACQ); (b) between the T/C ratio and both PA-21days and anxiety symptoms' severity (HARS). The results of the study suggest that testosterone is significantly associated to the severity of clinical manifestations of acute panic disorder, although in a different fashion concerning the two genders.
Keywords: Agoraphobia; Cortisol; Panic disorder; Testosterone.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Psychoticism in patients with panic disorder with or without comorbid agoraphobia.Int J Psychiatry Clin Pract. 2017 Sep;21(3):181-187. doi: 10.1080/13651501.2017.1305111. Epub 2017 Mar 27. Int J Psychiatry Clin Pract. 2017. PMID: 28345374
-
Correlations of plasma oxytocin with clinical and hormonal parameters in panic disorder.Nord J Psychiatry. 2023 Apr;77(3):221-226. doi: 10.1080/08039488.2022.2083675. Epub 2022 Jun 17. Nord J Psychiatry. 2023. PMID: 35714973
-
Baseline heartbeat perception accuracy and short-term outcome of brief cognitive-behaviour therapy for panic disorder with agoraphobia.Behav Cogn Psychother. 2015 Jul;43(4):426-35. doi: 10.1017/S135246581300101X. Epub 2013 Dec 13. Behav Cogn Psychother. 2015. PMID: 24330918
-
[Rethink the panic disorder].Encephale. 2010 Apr;36(2):100-4. doi: 10.1016/j.encep.2009.02.007. Epub 2009 Sep 11. Encephale. 2010. PMID: 20434625 Review. French.
-
The panic-agoraphobic spectrum: a descriptive approach to the assessment and treatment of subtle symptoms.Am J Psychiatry. 1997 Jun;154(6 Suppl):27-38. doi: 10.1176/ajp.154.6.27. Am J Psychiatry. 1997. PMID: 9167542 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical